Precipio, Inc. (PRPO)
NASDAQ · Manufacturing · Laboratory analytical instruments
PRPO price, last 12 months
Key stats
- Previous close
- $18.76
- Open
- $19.15
- Day range
- $18.47 – $19.28
- 52-week range
- $17.30 – $33.63
- Volume
- 28.4K
- Avg volume (20 days)
- 23.7K
- Market cap
- $39.7M
Performance
Technicals and fundamentals
About Precipio, Inc.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
- Sector
- Manufacturing
- Industry
- Laboratory analytical instruments
- Listed on
- NASDAQ
- Market cap
- $39.7M